Axsome Therapeutics, Inc (AXSM) Financials
Key financial figures for Axsome Therapeutics, Inc (Q2 2026).
- Revenue
- $218M
- Net Income
- -$51M
- EPS
- $-0.99
- Total Assets
- $761M
- Operating Cash Flow
- -$33M
Full income statement, balance sheet, and cash flow for Axsome Therapeutics, Inc on SentiSense.